The effect of repeated oral doses of quinine and quinidine on the circulation of dogs with renal hypertension was studied with measurements of arterial blood pressure and renal hemodynamics. Alkaloid concentrations up to the toxic range had little effect on the blood pressure or renal blood flow. It in dogs with renal hypertension, to assay the importance of the depressor action of these drugs directly on the smooth muscle of the arterioles or on the myocardium as separate from their sympatholytic effects. In such animals the hypertension is regarded as due to a humoral agent acting directly on the smooth muscle of arterioles with some stimulating action on the myocardium but with little contribution from sympathetic vasoconstrictor nerves.6 The experiments reported here show the lack of effect of repeated oral doses of quinine and quinidine on dogs with renal hypertension in contrast to the decrease in blood pressure seen with the same regimen in dogs with experimental neurogenic hypertension.
IT HAS been shown in this laboratory that orally administered cinchona alkaloids cause renal vasodilatation in normal dogs without much change in arterial blood pressure.' In dogs with experimental neurogenic hypertension these alkaloids cause a fall in the blood pressure as well as renal vasodilatation when administered in repeated oral doses.2 For a long time it has been known that when these drugs are given intravenously there is a sharp fall in blood pressure. Nelson, in a series of papers published in 1927, investigated this phenomenon and concluded that the depressor effect of intravenous quinine and quinidine was due to peripheral vasodilatation brought about partly by blockage of the vasomotor nerve endings and partly by a direct action on the arteriolar smooth muscle.3 He demonstrated that these drugs would antagonize the circulatory effects of epinephrine or splanchnic nerve stimulation. 4 We have recently confirmed these observations, with measurements of the effective plasma concentrations of alkaloid.5
It occurred to us that it might be possible, From in dogs with renal hypertension, to assay the importance of the depressor action of these drugs directly on the smooth muscle of the arterioles or on the myocardium as separate from their sympatholytic effects. In such animals the hypertension is regarded as due to a humoral agent acting directly on the smooth muscle of arterioles with some stimulating action on the myocardium but with little contribution from sympathetic vasoconstrictor nerves. 6 The experiments reported here show the lack of effect of repeated oral doses of quinine and quinidine on dogs with renal hypertension in contrast to the decrease in blood pressure seen with the same regimen in dogs with experimental neurogenic hypertension.
PROCEDURE
The experimental animals used in this work were female dogs, of the mongrel type, ranging in weight from 9 to 13.6 Kg. After control observations on blood pressure, the dogs were made hypertensive according to the method of Goldblatt.7 Briefly this method consists of constricting the main renal artery on each side by applying to it a metal clamp. The operation was done in two stages allowing time after the first clamp was applied for the animal to recover before clamping the artery on the other side.
After the final operation, if the (log showed a sustained rise in mean blood pressure, it was considered to be a renal hypertensive animal. 
RESULTS
The results of our experiments on all 5 dogs were essentially the same and are indicated in the accompanying graphic summaries of typical experiments.
In figure 1 it can be seen that a plasma concentration as high as 8 to 10 mg. per liter was achieved by repeated oral doses of quinidine sulfate as shown in the lower portion of the graph. In spite of the high concentration of alkaloid the blood pressure of this hypertensive dog showed little change as indicated by the height of the bars in the central part of the graph. In the upper section of the graph we have plotted the clearances of PAH, represented by the entire bar, and the clearances of creatinine as indicated by the black portion of each bar. Each bar represents an average of four clearance periods. The effective renal plasma flow-(PAH clearance) and the filtration rate (creatinine clearance) increased in this experiment during the interval of the experimental period but without relation to the plasma alkaloid concentration.
In figure 2 a very similar experiment is shown except that quinine sulfate was adminstered. In this experiment the plasma alkaloid concentration was not so high as that shown in figure 1 but still in the range which caused a marked fall in the blood pressure of dogs with neurogenic hypertension.2 In this experiment there was an apparent renal hyperemia during the administration of the drug, like that in normal dogs,' but this was not typical.
In figure 3 the contrast is shown between the effect of the cinchona alkaloids on dogs having renal hypertension and the effect on those with neurogenic hypertension. Blood concentrations of quinine and a slight hypotensive effect at all concentrations of quinidine.
In contrast, the data on the neurogenic hypertensive dogs, taken from the work of Hiatt2 In the beginning it was our intention to measure renal blood flow and glomerular filtra- scatter. The dogs used in our experiments showed no consistent change in renal hemodynamics with administration of cinchona alkaloids (another contrast with the neurogenic hypertensive dogs), but there was a general tendency for both effective renal plasma flow and glomerular filtration rate to increase with time after clamping the arteries.
The pulse rate, as in normal and neurogenic hypertensive animals, increased slightly or retion rate on all dogs before and after applying clamps to the renal arteries. But when it became apparent that in our hands the percentage of successful preparations was not high, we abandoned the control observations. However, we have compared the PAH and creatinine clearances of our has been demonstrated by the antagonism of quinine and quinidine to the circulatory effects of epinephrine and splanchnic nerve stimulation.8 The other two mechanisms apparently are not important as indicated by the above described lack of effect of the alkaloids (even at toxic plasma concentrations) on the blood pressure of dogs with renal hypertension. This view assumes that the maintenance of an arterial hypertension is evidence against an important depression of either arteriolar smooth muscle or myocardium. Ferrer 1. The blood pressure of renal hypertensive dogs was not significantly lowered at plasma alkaloid concentrations as high or higher than those which caused a sustained depressor effect on the blood pressure of neurogenic hypertensive dogs.
2. Mean renal clearances (creatinine and PAH) of the renal hypertensive dogs were reduced to 63 per cent of normal values. No consistent change due to the alkaloids was observed though the clearances tended to increase with time after the renal arteries were clamped.
3. The maintenance of blood pressure at plasma alkaloid concentrations as high as 10 mg. per liter indicated that neither arteriolar smooth muscle nor myocardium was markedly depressed and strengthens our impression that the depressor action of these drugs in normal animals is primarily at sympathetic neuromuscular vasomotor junctions.
